Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Chembio Diagnostics, Inc. is not a good value stock. Chembio Diagnostics, Inc. is not a good growth stock. Chembio Diagnostics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Chembio Diagnostics, Inc..

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnosti...

News

Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer

PR Newswire Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer Life Science Outsourcing, Inc. Welcomes Neil A. Goldman as Chief Financial Officer PR Newswire BREA, Calif., Oct...\n more…

Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com

Zolmax Equities research analysts at StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI Get Rating) in a research report issued to clients and investors on Sunday. The firm set a hold rating on the stock. Chembio Diagnostics Trading Up 0.2 % CEMI opened at $0.46 on Friday. Chembio ...\n more…

Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Chembio Diagnostics (NASDAQ:CEMI Get Rating) in a research report released on Sunday morning. The firm issued a hold rating on the stock. Chembio Diagnostics Trading Up 0.2 % Shares of CEMI stock opened at $0.46 on Friday. The stock has a 50 day ...\n more…

Insider Buying: Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Buys $17,777.70 in Stock

Zolmax Chembio Diagnostics, Inc. (NASDAQ:CEMI Get Rating) major shareholder Credit Advisors Ll Perceptive acquired 39,506 shares of the stock in a transaction that occurred on Monday, April 24th. The shares were bought at an average price of $0.45 per share, with a total value of $17,777.70. Following the ...\n more…

Insider Buying: Chembio Diagnostics, Inc. (NASDAQ:CEMI) Major Shareholder Buys 70,200 Shares of Stock

Zolmax Chembio Diagnostics, Inc. (NASDAQ:CEMI Get Rating) major shareholder Credit Advisors Ll Perceptive purchased 70,200 shares of Chembio Diagnostics stock in a transaction on Friday, April 21st. The stock was bought at an average price of $0.45 per share, with a total value of $31,590.00. ...\n more…

Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Globe Newswire Chembio Diagnostics, Inc. becomes the first North American structurecontrolled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (Biosynex) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced ...\n more…